Sagimet Biosciences Inc (SGMT) reported Loss for its second quarter that increased from the same period last year but beat the Street estimates.
The company's earnings totaled -$10.386 million, or -$0.32 per share. This compares with -$8.118 million, or -$0.25 per share, last year.
Analysts on average had expected the company to earn -$0.5 per share. Analysts' estimates typically exclude special items.
Sagimet Biosciences Inc earnings at a glance (GAAP) :
-Earnings: -$10.386 Mln. vs. -$8.118 Mln. last year.-EPS: -$0.32 vs. -$0.25 last year.
For comments and feedback contact: editorial@rttnews.com
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.